{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:51:15Z","timestamp":1765374675829,"version":"3.46.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Plasmablastic myeloma (PBM) is an extremely rare variant of multiple myeloma, having morphologic, clinical, and radiologic overlap with plasmablastic lymphoma (PBL). Thus, distinguishing both becomes vital due to different treatment strategies. Due to limited literature on imaging findings in this rare entity, here we present a unique case of PBM developing in the setting of chronic light chain myeloma, with extensive extramedullary involvement and severe osteopenia, in addition to pleural deposits, pleural effusion, and perinephric fascial deposit. Thus, 18F-FDG PET\/CT can be utilized as an important tool in distinguishing PBM and PBL on imaging, assessing disease extent, and identifying critical lesions requiring immediate intervention.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005857","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T10:10:32Z","timestamp":1744107032000},"page":"e57-e58","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["18F-FDG PET\/CT Findings in a Case of Plasmablastic Myeloma: A Rare Entity"],"prefix":"10.1097","volume":"51","author":[{"given":"Nivedita","family":"Kundu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Mahalik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dikhra","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"suppl 1","key":"R1-20251210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ijlh.13863","article-title":"Plasmablastic lymphoma: an update","volume":"44","author":"Bailly","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"R2-20251210","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.21873\/anticanres.15403","article-title":"Aggressive plasmablastic myeloma with extramedullary cord compression and hyperammonemic encephalopathy: case report and literature review","volume":"41","author":"Dah","year":"2021","journal-title":"Anticancer Res"},{"key":"R3-20251210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3960\/jslrt.24004","article-title":"Plasmablastic myeloma transformation of light-chain multiple myeloma","volume":"64","author":"Pakasticali","year":"2024","journal-title":"J Clin Exp Hematop JCEH"},{"key":"R4-20251210","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood.V91.7.2501","article-title":"Plasmablastic morphology\u2014an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) Myeloma Trial E9486 Report by the ECOG Myeloma Laboratory Group","volume":"91","author":"Greipp","year":"1998","journal-title":"Blood"},{"key":"R5-20251210","doi-asserted-by":"crossref","first-page":"e234436","DOI":"10.1136\/bcr-2020-234436","article-title":"Aggressive presentation of plasmablastic myeloma","volume":"13","author":"Suarez-Londono","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R6-20251210","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00428-022-03342-3","article-title":"Plasmablastic myeloma in Taiwan frequently presents with extramedullary and extranodal mass mimicking plasmablastic lymphoma","volume":"481","author":"Chen","year":"2022","journal-title":"Virchows Arch Int J Pathol"},{"key":"R7-20251210","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1097\/RLU.0000000000005584","article-title":"FDG PET\/CT in Cutaneous Involvement of Plasmablastic Plasma Cell Myeloma.","volume":"50","author":"Mohamed","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R8-20251210","first-page":"194","article-title":"[Plasmablastic myeloma initially presented with ascites]","volume":"63","author":"Sato","year":"2022","journal-title":"Rinsho Ketsueki"},{"key":"R9-20251210","first-page":"e32600","article-title":"A case of plasmablastic multiple myeloma with extramedullary disease manifesting as a myelomatous pleural effusion","volume":"14","author":"Jiffry","year":"2022","journal-title":"Cureus"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:01:21Z","timestamp":1765371681000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005857","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"type":"print","value":"0363-9762"},{"type":"electronic","value":"1536-0229"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"2025-01-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}